Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Breast Cancer

  Free Subscription


Articles published in Int J Radiat Oncol Biol Phys

Retrieve available abstracts of 218 articles:
HTML format



Single Articles


    July 2024
  1. BEYDOUN H, Griffith KA, Jagsi R, Burmeister JW, et al
    Are We Missing Acute Toxicities Associated With Hypofractionated Breast Irradiation? A Report From a Large Multicenter Cohort Study.
    Int J Radiat Oncol Biol Phys. 2024;119:1092-1098.
    PubMed     Abstract available


  2. ASHA W, Al-Hilli Z, Djohan R, Budd GT, et al
    Neoadjuvant Reirradiation for Radiation Therapy-Associated Angiosarcoma of the Breast.
    Int J Radiat Oncol Biol Phys. 2024;119:1082-1085.
    PubMed     Abstract available


  3. HEPEL JT, Leonard KL, Yashar CM, Einck JP, et al
    Phase II Trial of Five-Fraction Accelerated Partial Breast Irradiation Using Noninvasive Image-Guided Breast Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2024;119:878-883.
    PubMed     Abstract available


    June 2024
  4. YIT LFN, Quek ZHS, Tan JYT, Tan BF, et al
    Curative Approaches for Metaplastic Breast Cancer: A Retrospective Cohort Outcome Review.
    Int J Radiat Oncol Biol Phys. 2024 Jun 29:S0360-3016(24)00751.
    PubMed     Abstract available


  5. ZHOU YY, Li YN, Xu JF, Chen B, et al
    Rapid Selection of Patients Suitable for Deep Inspiration Breath-Hold Using an Automatic Delineating System and RapidPlan Model in Left Breast Cancer Patients undergoing Adjuvant Radiotherapy with IMRT.
    Int J Radiat Oncol Biol Phys. 2024 Jun 26:S0360-3016(24)00739.
    PubMed     Abstract available


  6. LO AC, Ronckers C, Aznar MC, Avanzo M, et al
    Breast Hypoplasia and Decreased Lactation From Radiation Therapy in Survivors of Pediatric Malignancy: A PENTEC Comprehensive Review.
    Int J Radiat Oncol Biol Phys. 2024;119:549-559.
    PubMed     Abstract available


    May 2024
  7. HAHN EA, Pugh SL, Lu HL, Vela AM, et al
    Validation of Patient-Reported Outcomes in Patients With Nonmetastatic Breast Cancer Receiving Comprehensive Nodal Irradiation in the RadComp Trial.
    Int J Radiat Oncol Biol Phys. 2024 May 13:S0360-3016(24)00436.
    PubMed     Abstract available


  8. KOLEOSO O, Toumbacaris N, Brogi E, Zhang Z, et al
    The presence of extensive lymphovascular invasion (LVI) is associated with higher risks of local-regional recurrence compared to usual LVI in curatively treated breast cancer patients.
    Int J Radiat Oncol Biol Phys. 2024 May 4:S0360-3016(24)00625.
    PubMed     Abstract available


    April 2024
  9. YONEYAMA M, Zormpas-Petridis K, Robinson R, Sobhani F, et al
    Longitudinal assessment of tumor-infiltrating lymphocytes in primary breast cancer following neoadjuvant radiotherapy.
    Int J Radiat Oncol Biol Phys. 2024 Apr 26:S0360-3016(24)00566.
    PubMed     Abstract available


  10. KIM E, Yoo JS, Kim YJ, Joo J, et al
    Toxicity evaluation of dose-escalation in hypofractionated regional nodal irradiation for breast cancer: a retrospective study.
    Int J Radiat Oncol Biol Phys. 2024 Apr 15:S0360-3016(24)00513.
    PubMed     Abstract available


  11. ROGE M, Kirova Y, Leveque E, Guigo M, et al
    Impact of radiation therapy modalities on loco-regional control in inflammatory breast cancer.
    Int J Radiat Oncol Biol Phys. 2024 Apr 13:S0360-3016(24)00506.
    PubMed     Abstract available


  12. LOVING BA, Almahariq MF, Sivapalan S, Levitin R, et al
    Newly Diagnosed Mental Health Disorders in Patients with Breast Cancer Receiving Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2024 Apr 4:S0360-3016(24)00445.
    PubMed     Abstract available


  13. KIROVA YM, Loap P
    Improving the Treatment of Brain Metastases in HER2-Positive Breast Cancers: Eternal Dream or Reality? Results of the NRG Oncology-KROG/RTOG 1119 Phase 2 Randomized Trial and Future Directions.
    Int J Radiat Oncol Biol Phys. 2024;118:1402-1403.
    PubMed    


  14. KHAN AJ, Marine CB, Flynn J, Tyagi N, et al
    A Phase II Study Evaluating the Effect of Intensity-Modulated Post-Mastectomy Radiation Therapy on Implant Failure Rates in Breast Cancer Patients with Immediate, 2-Stage Implant Reconstruction, with an MRI imaging correlative substudy.
    Int J Radiat Oncol Biol Phys. 2024 Apr 1:S0360-3016(24)00451.
    PubMed     Abstract available


    March 2024
  15. SHEVA K, Chowdhury SR, Kravchenko-Balasha N, Meirovitz A, et al
    Molecular changes in breast cancer induced by radiation therapy.
    Int J Radiat Oncol Biol Phys. 2024 Mar 18:S0360-3016(24)00435.
    PubMed     Abstract available


  16. SILVERWOOD S, Lichter K, Conway A, Drew T, et al
    Distance Traveled by Patients Globally to Access Radiation Therapy: A Systematic Review.
    Int J Radiat Oncol Biol Phys. 2024;118:891-899.
    PubMed     Abstract available


  17. LAUGHLIN BS, Corbin KS, Toesca DAS, Thorpe CS, et al
    Physician- and Patient-Reported Outcomes of the MC1635 Phase 3 Trial of Ultrahypofractionated Versus Moderately Hypofractionated Adjuvant Radiation Therapy After Breast-Conserving Surgery.
    Int J Radiat Oncol Biol Phys. 2024;118:1049-1059.
    PubMed     Abstract available


  18. GRENDAROVA P, Roumeliotis M, Quirk S, Phan T, et al
    Accelerated Partial Breast Irradiation Using 5 Daily Fractions: A Prospective, Phase 2, Multicenter Trial of Cosmetic Outcomes and Toxicity-ACCEL Final Results.
    Int J Radiat Oncol Biol Phys. 2024;118:1041-1048.
    PubMed     Abstract available


  19. BEHZADI ST, Moser R, Kiesl S, Nano J, et al
    Tumor Contact with Internal Mammary Perforator Vessels as Risk Factor for Gross Internal Mammary Lymph Node Involvement in Breast Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2024 Mar 6:S0360-3016(24)00339.
    PubMed     Abstract available


  20. YASHAYAEVA A, Dahn H, Svatos M, Zhan K, et al
    A Prospective Study Demonstrating Early Prediction of Skin Toxicity From Radiation Therapy Using Radiomic Features From Optical and Infrared Images.
    Int J Radiat Oncol Biol Phys. 2024;118:839-852.
    PubMed     Abstract available


  21. WU VS, Khlopin M, Chadha M, Smith-Graziani DJ, et al
    Out-of-pocket cost modeling of adjuvant antiestrogen and radiation therapy after lumpectomy for early-stage breast cancer across Medicaid and Medicare plans.
    Int J Radiat Oncol Biol Phys. 2024 Mar 1:S0360-3016(24)00351.
    PubMed     Abstract available


    February 2024
  22. CACHO-DIAZ B, Tripathy D, Arrieta VA, Escamilla-Ramirez A, et al
    Real-world experience in Hispanic Patients with Breast Cancer and Brain Metastases using different Prognostic Tools.
    Int J Radiat Oncol Biol Phys. 2024 Feb 14:S0360-3016(24)00305.
    PubMed     Abstract available


  23. OHRI N, George M, Omene C, Haffty B, et al
    The Present and Future of Postmastectomy Radiation.
    Int J Radiat Oncol Biol Phys. 2024;118:466-467.
    PubMed    


  24. BAZAN JG, Corn BW
    Surgical De-escalation in Breast Cancer: Qualitative Research Introduces Hope for Patients and Illuminates a Blind Spot Within Blinded Studies.
    Int J Radiat Oncol Biol Phys. 2024;118:455-457.
    PubMed    


  25. NOVICK K, Chadha M, Daroui P, Freedman G, et al
    American Radium Society Appropriate Use Criteria Postmastectomy Radiation Therapy: Executive Summary of Clinical Topics.
    Int J Radiat Oncol Biol Phys. 2024;118:458-465.
    PubMed     Abstract available


  26. PETRY V, Bonadio RC, Moutinho K, Leite LS, et al
    Frequency of radiotherapy-induced malignancies in Li-Fraumeni Syndrome patients with early-stage breast cancer and influence of the radiotherapy technique.
    Int J Radiat Oncol Biol Phys. 2024 Feb 1:S0360-3016(24)00249.
    PubMed     Abstract available


    January 2024
  27. VERMA S, Young S, Boldt G, Blanchette P, et al
    Immunotherapy and Radiation therapy Sequencing in Breast Cancer: A Systematic Review.
    Int J Radiat Oncol Biol Phys. 2024 Jan 7:S0360-3016(24)00006.
    PubMed     Abstract available


  28. WRIGHT JL, Bazan JG
    Time to Reconsider the Role of Diagnostic Chest Computed Tomography in Early-Stage Breast Cancer?
    Int J Radiat Oncol Biol Phys. 2024;118:104-106.
    PubMed    


    December 2023
  29. HOWARD K, Norris S, Salisbury A, Pearce A, et al
    Women's preferences for hypofractionated radiation therapy for treatment of early-stage breast cancer: a discrete choice experiment.
    Int J Radiat Oncol Biol Phys. 2023 Dec 16:S0360-3016(23)08155.
    PubMed     Abstract available


  30. KARLSEN J, Tandstad T, Steinshamn S, Salvesen O, et al
    Pulmonary Function and Lung Fibrosis up to 12 Years After Breast Cancer Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2023 Dec 14:S0360-3016(23)08034.
    PubMed     Abstract available


  31. PATEL TA, Jain B, Vapiwala N, Chino F, et al
    Trends in Utilization and Medicare Spending on Short-Course Radiotherapy for Breast and Prostate Cancer: An Episode-Based Analysis from 2015-2019.
    Int J Radiat Oncol Biol Phys. 2023 Dec 8:S0360-3016(23)08173.
    PubMed     Abstract available


  32. LYONS JA
    Second Breast Conserving Therapy: Who, What, When, and How?
    Int J Radiat Oncol Biol Phys. 2023;117:1211-1212.
    PubMed    


    November 2023
  33. BEINER C, Qureshi MM, Zhao J, Hu B, et al
    Depression and Anxiety Among English and Spanish-Speaking Patients with Breast Cancer Receiving Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2023 Nov 30:S0360-3016(23)08183.
    PubMed     Abstract available


  34. IYER P, Krishnamurth A, Velusamy S, Sundersingh S, et al
    Impact of Neoadjuvant Concurrent Chemoradiation (NACCRT) on Operability and Survival in Locally Advanced Inoperable Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2023 Nov 28:S0360-3016(23)08168.
    PubMed     Abstract available


  35. RODIN D, Bazan JG
    The Internal Mammary Node Irradiation Debate in Node-Positive Breast Cancer: Case Closed.
    Int J Radiat Oncol Biol Phys. 2023;117:779-782.
    PubMed    


  36. YUAN J, Alcorn SR
    Recurrent Breast Cancer With Contralateral Axillary Metastasis Treated With Curative Intent.
    Int J Radiat Oncol Biol Phys. 2023;117:528.
    PubMed    


  37. MOKHTECH M, Knowlton CA
    Bilateral Breast Cancer With Contralateral Axillary Metastasis Warrants Aggressive Treatment: Let's Go for It!
    Int J Radiat Oncol Biol Phys. 2023;117:527-528.
    PubMed    


  38. LEE JH, Tye K
    A Bear of an Aberrant Case: Bilateral Breast Malignancies in a Woman With Previous History of Breast Radiation.
    Int J Radiat Oncol Biol Phys. 2023;117:526.
    PubMed    


    October 2023
  39. LEEMAN JE, Lapen K, Fuchs HE, Gonen M, et al
    Cardiorespiratory fitness in early-stage breast cancer patients with radiotherapy-related fatigue: A prospective pilot study.
    Int J Radiat Oncol Biol Phys. 2023 Oct 30:S0360-3016(23)08042.
    PubMed     Abstract available


  40. GUHAN M, Crane SM, Valerius LS, Cruz D, et al
    Patient interest in exploring non-surgical treatment approaches for early stage breast cancer: A qualitative study.
    Int J Radiat Oncol Biol Phys. 2023 Oct 4:S0360-3016(23)07909.
    PubMed     Abstract available


  41. MUSHONGA M, LaVigne AW, Alcorn SR
    Improving Characterization and Management of Acute Radiation Skin Toxicity Across Skin Tones in Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2023;117:479-481.
    PubMed    


  42. OLADERU OT, Bradley JA
    Beyond Axillary Surgery De-escalation: Imperative Vigilance on Regional Nodal Irradiation's Impact on Breast Cancer Treatment-Related Lymphedema.
    Int J Radiat Oncol Biol Phys. 2023;117:465-467.
    PubMed    


  43. NAOUM GE, Taghian AG
    Regional Lymph Node Radiation Is Not the Main Risk Factor for Breast Cancer Related Lymphedema: Stop Chasing Radiation Doses, Fractionation or Techniques-Focus on Axillary Surgery De-escalation or Prevention.
    Int J Radiat Oncol Biol Phys. 2023;117:461-464.
    PubMed    


    September 2023
  44. DIAO K, Lei X, He W, Jagsi R, et al
    Racial and Ethnic Differences in Long-Term Adverse Radiotherapy Effects among Breast Cancer Survivors.
    Int J Radiat Oncol Biol Phys. 2023 Sep 24:S0360-3016(23)07935.
    PubMed     Abstract available


  45. O'BRIEN DR, Boe L, Montagna G, Mueller B, et al
    Accelerated Partial Breast Irradiation for HER2-Positive Early-Stage Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2023 Sep 24:S0360-3016(23)07896.
    PubMed     Abstract available


  46. JEON SH, Jang BS, Kim DY, Kim JH, et al
    Dynamic responses of circulating T cells following stereotactic body radiotherapy for bone metastasis in patients with breast cancer.
    Int J Radiat Oncol Biol Phys. 2023 Sep 22:S0360-3016(23)07932.
    PubMed     Abstract available


  47. HERR DJ, Moncion A, Griffith KA, Marsh R, et al
    Factors associated with cardiac radiation dose reduction following hypofractionated radiation therapy for localized, left-sided breast cancer in a large statewide quality consortium.
    Int J Radiat Oncol Biol Phys. 2023 Sep 15:S0360-3016(23)07926.
    PubMed     Abstract available


  48. ZABROCKA E, Polce S, Roberson JD, Wu J, et al
    Utility of Stereotactic Body Radiation Therapy (SBRT) in Establishing Local Control for Invasive Breast Cancer Patients Not Undergoing Definitive Surgery.
    Int J Radiat Oncol Biol Phys. 2023 Sep 12:S0360-3016(23)07908.
    PubMed     Abstract available


    July 2023
  49. KIM IA, Winter KA, Sperduto PW, Santos JFL, et al
    Concurrent lapatinib with brain radiotherapy in HER2+ breast cancer patients with brain metastases - NRG ONCOLOGY-KROG/ RTOG 1119 phase II randomized trial.
    Int J Radiat Oncol Biol Phys. 2023 Jul 26:S0360-3016(23)07681.
    PubMed     Abstract available


  50. SARAF A, Tahir I, Hu B, Dietrich AW, et al
    Sarcopenia and toxicity-related discontinuation of endocrine therapy in women with early-stage hormone-receptor-positive breast cancer.
    Int J Radiat Oncol Biol Phys. 2023 Jul 26:S0360-3016(23)07679.
    PubMed     Abstract available


  51. DE ROSE F, Mussari S, Di Brina L, Ravanelli D, et al
    Whole Breast Irradiation Versus Intraoperative Electron Radiation Therapy for Breast Conserving Therapy: A Large Mature Single Institution Matched-Pair Evaluation of True Local Relapse, Progression Free Survival, and Overall Survival.
    Int J Radiat Oncol Biol Phys. 2023;116:757-769.
    PubMed     Abstract available


  52. HANNOUN-LEVI JM, Gal J, Polgar C, Strnad V, et al
    Second conservative treatment for local recurrence breast cancer: a GEC-ESTRO oncological outcome and prognostic factor analysis.
    Int J Radiat Oncol Biol Phys. 2023 Jul 15:S0360-3016(23)02194.
    PubMed     Abstract available


  53. SHIN J, Chang JS, Kim JS, An JY, et al
    An Investigation of the Impact of Virtual Reality on Alleviating Anxiety in Patients with Breast Cancer Undergoing Radiotherapy: A Randomized Controlled Trial.
    Int J Radiat Oncol Biol Phys. 2023 Jul 12:S0360-3016(23)04706.
    PubMed     Abstract available


  54. BALBACH ML, Sherry AD, Rexer BN, Abramson VG, et al
    Feasibility and Tolerability of Adjuvant Capecitabine-Based Chemoradiation in Breast Cancer Patients with Residual Disease following Neoadjuvant Chemotherapy: A Prospective Clinical Trial.
    Int J Radiat Oncol Biol Phys. 2023 Jul 9:S0360-3016(23)02196.
    PubMed     Abstract available


  55. PISANO CE, Kharouta MZ, Harris EE, Shenk R, et al
    Reduced Dose Radiotherapy and Concurrent Paclitaxel Chemotherapy in Lymph Node Positive Breast Cancer: Long term follow-up of a single-institution prospective study.
    Int J Radiat Oncol Biol Phys. 2023 Jul 3:S0360-3016(23)00589.
    PubMed     Abstract available


  56. KUO AM, Lee EH, Rossi AM, Nehal KS, et al
    A Multicenter Prospective Trial of Electronic Skin Surface Brachytherapy for Keratinocyte Carcinoma: Early Cosmesis, Quality of Life, and Adverse Events.
    Int J Radiat Oncol Biol Phys. 2023;116:544-550.
    PubMed     Abstract available


    June 2023
  57. LI C, Wang X, Liao J, Chen F, et al
    Combined Aurora Kinase A and CHK1 Inhibition enhances radiosensitivity of triple-negative breast cancer through induction of apoptosis and mitotic catastrophe associated with excessive DNA damage.
    Int J Radiat Oncol Biol Phys. 2023 Jun 29:S0360-3016(23)00615.
    PubMed     Abstract available


    May 2023
  58. FORSTER T, Kohler C, Dorn M, Hafner MF, et al
    Non-inferiority of local control and comparable toxicity of intensity-modulated radiotherapy with simultaneous integrated boost in breast cancer: 5-year results of the IMRT-MC2 phase III trial: IMRT-SIB is non-inferior to 3-D-CRT-seqB in RT for BC pat
    Int J Radiat Oncol Biol Phys. 2023 May 25:S0360-3016(23)00523.
    PubMed     Abstract available


  59. BYUN HK, Chang JS, Kim H, Kim J, et al
    Cosmetic outcome and toxicity after stereotactic accelerated partial breast irradiation in early breast cancer: A prospective observational cohort study.
    Int J Radiat Oncol Biol Phys. 2023 May 16:S0360-3016(23)00464.
    PubMed     Abstract available


  60. ALVAREZ DSA, Watson PGF, Popovic M, Heng VJ, et al
    Evaluation of Dosimetry Formalisms in Intraoperative Radiotherapy of Glioblastoma: Dosimetry formalisms in IORT of glioblastoma.
    Int J Radiat Oncol Biol Phys. 2023 May 5:S0360-3016(23)00439.
    PubMed     Abstract available


  61. LAVIGNE AW, DeWeese TL, Wright JL, Deville C Jr, et al
    Radiotherapy Deserts: The Impact of Race, Poverty, and the Rural-Urban Continuum on Density of Providers and the Use of Radiation Therapy in the US.
    Int J Radiat Oncol Biol Phys. 2023;116:17-27.
    PubMed     Abstract available


    April 2023
  62. HEALY E, Beyer S, Jhawar S, White JR, et al
    The Axillary Lateral Vessel Thoracic Junction is Not an Organ-at-Risk for Breast Cancer Related Lymphedema.
    Int J Radiat Oncol Biol Phys. 2023 Apr 12:S0360-3016(23)00362.
    PubMed     Abstract available


    March 2023
  63. WANG DQ, Zhang N, Dong LH, Zhong YH, et al
    Dose-volume predictors for radiation esophagitis in breast cancer patients undergoing hypofractionated regional nodal radiotherapy.
    Int J Radiat Oncol Biol Phys. 2023 Mar 29:S0360-3016(23)00304.
    PubMed     Abstract available


  64. HEPEL JT, Loap P, Fourquet A, Kirova YM, et al
    DCIS Update: Escalation or De-escalation? Boost, Fractionation, and Omission of Radiation.
    Int J Radiat Oncol Biol Phys. 2023;115:813-816.
    PubMed    


  65. REDDY JP, Lei X, Bloom ES, Reed VK, et al
    Optimizing Preventive Adjuvant Linac-Based (OPAL) Radiation: A Phase 2 Trial of Daily Partial Breast Irradiation.
    Int J Radiat Oncol Biol Phys. 2023;115:629-644.
    PubMed     Abstract available


  66. CHATTERJEE S, Chakrabarty S, Santosham R, Saha A, et al
    Alleviating morbidity from locally advanced breast cancer using a practical and short radiotherapy regime: Results of the HYPORT palliative studies.
    Int J Radiat Oncol Biol Phys. 2023 Mar 1:S0360-3016(23)00154.
    PubMed     Abstract available


  67. HOLT F, Probert J, Darby S, Haviland JS, et al
    Proton Beam Therapy for Early Breast Cancer: A Systematic Review and Meta-analysis of Clinical Outcomes.
    Int J Radiat Oncol Biol Phys. 2023 Mar 1:S0360-3016(23)00168.
    PubMed     Abstract available


    February 2023
  68. LIVERINGHOUSE CL, Mills MN, Ahmed KA, Washington IR, et al
    Phase II Study of Preoperative Stereotactic Ablative Body Radiotherapy for Early-Stage Breast Cancer: Introduction of a Novel Form of Accelerated Partial Breast Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2023 Feb 14:S0360-3016(22)03689.
    PubMed     Abstract available


  69. PARK YI, Chang JS, Ko H, Im SH, et al
    Development and validation of a normal tissue complication probability model for lymphedema after radiotherapy in breast cancer.
    Int J Radiat Oncol Biol Phys. 2023 Feb 3:S0360-3016(23)00106.
    PubMed     Abstract available


    January 2023
  70. TALCOTT WJ, Cain DM, Yang D, Mougalian SS, et al
    Aging a Decade in a Day: Age Cutoff Bias in Adjuvant Therapy Allocation for Early-Stage Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2023 Jan 31:S0360-3016(23)00010.
    PubMed     Abstract available


  71. SHI JJ, Lei X, Chen YS, Chavez-MacGregor M, et al
    Socioeconomic Barriers to Randomized Clinical Trial Retention in Patients Treated with Adjuvant Radiation for Early-Stage Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2023 Jan 29:S0360-3016(23)00079.
    PubMed     Abstract available


  72. VASSANTACHART A, Ragab O, Miller K, Lock D, et al
    Knowledge and understanding of radiation therapy among breast cancer patients from culturally diverse backgrounds at a safety-net hospital.
    Int J Radiat Oncol Biol Phys. 2023 Jan 28:S0360-3016(23)00077.
    PubMed     Abstract available


  73. WARD MC, Fasola CE, White RL Jr, Bentzen SM, et al
    In Regard to Vaidya et al.
    Int J Radiat Oncol Biol Phys. 2023;115:255-256.
    PubMed    


  74. WOODWARD WA, Mitchell MP
    The Elusive Prize of Radiation Therapy Predictive Assays in Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2023;115:103-105.
    PubMed    


  75. GOLDBERG M, Bridhikitti J, Khan AJ, McGale P, et al
    A Meta-Analysis of Trials of Partial Breast Irradiation.
    Int J Radiat Oncol Biol Phys. 2023;115:60-72.
    PubMed     Abstract available


  76. VICINI FA, Mann GB, Shah C, Weinmann S, et al
    A Novel Biosignature Identifies Patients With DCIS With High Risk of Local Recurrence After Breast Conserving Surgery and Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2023;115:93-102.
    PubMed     Abstract available


  77. VAIDYA JS, Bulsara M, Wenz F, Sperk E, et al
    The TARGIT-A Randomized Trial: TARGIT-IORT Versus Whole Breast Radiation Therapy: Long-Term Local Control and Survival.
    Int J Radiat Oncol Biol Phys. 2023;115:77-82.
    PubMed    


    December 2022
  78. WANG B, Liu W, Liu C, Du K, et al
    Cancer-associated fibroblasts promote radioresistance of breast cancer cells via the HGF/c-Met signaling pathway.
    Int J Radiat Oncol Biol Phys. 2022 Dec 28:S0360-3016(22)03679.
    PubMed     Abstract available


  79. WARD MC, Recht A, Vicini F, Al-Hilli Z, et al
    Cost-Effectiveness Analysis of Ultra-Hypofractionated Whole Breast Radiation Therapy Alone vs. Endocrine Therapy Alone or Combined Treatment for Low-Risk ER-positive Early-Stage Breast Cancer in Women Age 65 and Older.
    Int J Radiat Oncol Biol Phys. 2022 Dec 28:S0360-3016(22)03678.
    PubMed     Abstract available


  80. ATHALE J, Broderick K, Wu X, Grossman S, et al
    Evidence for Persistent Radiation Related Injury to the Immune System in Patients with Local Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2022 Dec 14:S0360-3016(22)03556.
    PubMed     Abstract available


  81. KATIPALLY RR, Olson AC, Chmura SJ
    Flipping the Null: Lessons From Breast Cancer and Recalibrating Expectations in Oligometastases.
    Int J Radiat Oncol Biol Phys. 2022;114:840-842.
    PubMed    


    November 2022
  82. BATENBURG MCT, van der Molen DRM, van der Leij F, Doeksen A, et al
    Patient-reported symptoms of late toxicity in breast cancer patients treated with hypofractionated radiotherapy and the association with quality of life.
    Int J Radiat Oncol Biol Phys. 2022 Nov 16:S0360-3016(22)03523.
    PubMed     Abstract available


  83. GOODMAN CR, Strauss JB
    One Way or Another: An Oligorecurrence After an Oligometastasis of an Estrogen Receptor-Positive Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2022;114:571-572.
    PubMed    


  84. JING H, Tang Y, Wang ZZ, Wei R, et al
    Individualized Clinical Target Volume for Irradiation of the Supraclavicular Region in Breast Cancer Based on Mapping of the Involved Ipsilateral Supraclavicular Lymph Nodes.
    Int J Radiat Oncol Biol Phys. 2022 Nov 8. pii: S0360-3016(22)03513.
    PubMed     Abstract available


  85. ALCORN SR, Wright JL
    Toxicity and Timing of Breast Radiation Therapy With Overlapping Systemic Therapies.
    Int J Radiat Oncol Biol Phys. 2022;114:377-381.
    PubMed    


  86. AL-RASHDAN A, Quirk S, Roumeliotis M, Abedin T, et al
    Radiation Therapy With Cyclin-Dependent Kinase 4/6 Inhibitors: A Multi-institutional Safety and Toxicity Study.
    Int J Radiat Oncol Biol Phys. 2022;114:399-408.
    PubMed     Abstract available


  87. BARNETT GC, Kerns SL, Dorling L, Fachal L, et al
    No Association Between Polygenic Risk Scores for Cancer and Development of Radiation Therapy Toxicity.
    Int J Radiat Oncol Biol Phys. 2022;114:494-501.
    PubMed     Abstract available


    October 2022
  88. HARDY-ABELOOS C, Karp J, Xiao J, Oh C, et al
    Disparities in the uptake of telemedicine and implications for clinical trial enrollment in breast cancer patients.
    Int J Radiat Oncol Biol Phys. 2022 Oct 20. pii: S0360-3016(22)03447.
    PubMed     Abstract available


  89. ANAKWENZE AKINFENWA CP, Strom EA
    From the Plexus to the Cord: A Case of Metastatic Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2022;114:181-182.
    PubMed    


    September 2022
  90. ZHANG YH, Montagna G, Flynn J, Gillespie EF, et al
    Outcomes of Breast Cancer Patients with High Volume of Residual Disease Following Neoadjuvant Chemotherapy.
    Int J Radiat Oncol Biol Phys. 2022 Sep 22. pii: S0360-3016(22)03390.
    PubMed     Abstract available


  91. LIU J, Chen YJ, Williams TM, Fields E, et al
    Evaluation of Radiation Oncologist and Trainee Opinions on Residency Expansion, Possible Actions, and Training Program Accreditation Changes in the United States.
    Int J Radiat Oncol Biol Phys. 2022;114:16-20.
    PubMed     Abstract available


  92. KAPADIA NS, Brooks GA, Landrum MB, Riedel L, et al
    Association of the Oncology Care Model With Value-Based Changes in Use of Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2022;114:39-46.
    PubMed     Abstract available


    August 2022
  93. HASSAN MZO, Awadalla M, Tan TC, Scherrer-Crosbie M, et al
    Serial Measurement of Global Longitudinal Strain among Women with Breast Cancer treated with Proton Radiation Therapy: A Prospective Trial for 70 Patients.
    Int J Radiat Oncol Biol Phys. 2022 Aug 23. pii: S0360-3016(22)03141.
    PubMed     Abstract available


  94. JACOMINA LE, Eala MAB, Mejia MBA, Baldivia KH, et al
    Utilization of Hypofractionated Radiation Therapy for Breast Cancer: Perspectives From the Philippines.
    Int J Radiat Oncol Biol Phys. 2022;113:925-927.
    PubMed    


    July 2022
  95. SIMONETTO C, Kaiser JC, van den Bogaard VAB, Langendijk JA, et al
    Breast cancer radiotherapy and the risk of acute coronary events - insights from a process oriented model.
    Int J Radiat Oncol Biol Phys. 2022 Jul 1. pii: S0360-3016(22)00645.
    PubMed     Abstract available


  96. AL-RASHDAN A, Cao J
    A Viewpoint on Isolated Contralateral Axillary Lymph Node Involvement by Breast Cancer: Regional Recurrence or Distant Metastasis?
    Int J Radiat Oncol Biol Phys. 2022;113:489.
    PubMed    


  97. MAILHOT VEGA RB, Wang S, Brooks ED, Oladeru OT, et al
    Evaluating Regional Nodal Irradiation Allocation and Association with Oncologic Outcomes in NSABP B-18, B-27, B-40, and B-41.
    Int J Radiat Oncol Biol Phys. 2022;113:542-551.
    PubMed     Abstract available


  98. JACOBS DHM, Mast ME, Horeweg N, Speijer G, et al
    Accelerated Partial Breast Irradiation Using External Beam or Intraoperative Electron Radiation Therapy: 5-Year Oncological Outcomes of a Prospective Cohort Study.
    Int J Radiat Oncol Biol Phys. 2022;113:570-581.
    PubMed     Abstract available


    June 2022
  99. LAPEN K, King C, Braunstein LZ, Khan AJ, et al
    A Comparison of Patient- and Clinician-Reported Acute Toxicity During Radiotherapy for Primary Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2022 Jun 5. pii: S0360-3016(22)00548.
    PubMed     Abstract available


  100. ZHAO XR, Fang H, Jing H, Tang Y, et al
    Radiation-induced hypothyroidism in patients with breast cancer after hypofractionated radiotherapy: A prospective cohort study.
    Int J Radiat Oncol Biol Phys. 2022 Jun 5. pii: S0360-3016(22)00557.
    PubMed     Abstract available


  101. DILWORTH JT, Griffith KA, Pierce LJ, Jagsi R, et al
    The Impact of Chemotherapy on Toxic Effects and Cosmetic Outcome in Patients Receiving Whole Breast Irradiation: An Analysis Within a Statewide Quality Consortium.
    Int J Radiat Oncol Biol Phys. 2022;113:266-277.
    PubMed     Abstract available


    May 2022
  102. ZHANG L, Liu J, Ma J, Mei X, et al
    Entire versus Medial Supraclavicular Nodal Irradiation for Patients with High-risk Node-positive Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2022 May 30. pii: S0360-3016(22)00479.
    PubMed     Abstract available


  103. SHUKLA U, Sueyoshi M, Diamond B, Chowdhury I, et al
    Disparities in Radiation Therapy: Practice Patterns Analysis of Deep Inspiratory Breath Hold Use in Non-English Speakers.
    Int J Radiat Oncol Biol Phys. 2022;113:21-25.
    PubMed     Abstract available


    April 2022
  104. ZUREICK AH, Grzywacz VP, Almahariq MF, Silverman BR, et al
    Dose to the Left Anterior Descending Artery Correlates with Cardiac Events Following Irradiation for Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2022 Apr 25. pii: S0360-3016(22)00332.
    PubMed     Abstract available


  105. DOSANI M, Hamilton S, Gondara L, Speers C, et al
    pN0(i+) and pN1mi Breast Cancer: Treatment and Outcomes in Comparison to pN0 and pN1a in the Modern Era.
    Int J Radiat Oncol Biol Phys. 2022 Apr 3. pii: S0360-3016(22)00275.
    PubMed     Abstract available


  106. MIGNOT F, Quero L, Guillerm S, Benadon B, et al
    Ten-Year Outcomes of Hypofractionated Postmastectomy Radiation Therapy of 26 Gy in 6 Fractions.
    Int J Radiat Oncol Biol Phys. 2022;112:1105-1114.
    PubMed     Abstract available


    March 2022
  107. ANDRING LM, Diao K, Sun S, Patel M, et al
    Locoregional Management and Prognostic Factors in Breast Cancer Patients with Ipsilateral Internal Mammary and Axillary Lymph Node Involvement.
    Int J Radiat Oncol Biol Phys. 2022 Mar 3. pii: S0360-3016(22)00192.
    PubMed     Abstract available


  108. NICHOL A, Narinesingh D, Wade L, Raman S, et al
    Breast Tangent Beam Energy, Surgical Bed-to-Skin Distance and Local Recurrence After Breast-Conserving Treatment.
    Int J Radiat Oncol Biol Phys. 2022;112:671-680.
    PubMed     Abstract available


    February 2022
  109. VERBANCK S, Van Parijs H, Schuermans D, Vinh-Hung V, et al
    Lung Restriction in Breast Cancer Patients after Hypofractionated Tomotherapy and Conventional 3D Conformal Radiotherapy: a 10-year Follow-up.
    Int J Radiat Oncol Biol Phys. 2022 Feb 25. pii: S0360-3016(22)00167.
    PubMed     Abstract available


  110. CHAPMAN BV, Liu D, Shen Y, Olamigoke OO, et al
    Outcomes After Breast Radiation Therapy in a Diverse Patient Cohort With a Germline BRCA1/2 Mutation.
    Int J Radiat Oncol Biol Phys. 2022;112:426-436.
    PubMed     Abstract available


  111. CHAPMAN BV, Liu D, Shen Y, Olamigoke OO, et al
    Breast Radiation Therapy-Related Treatment Outcomes in Patients With or Without Germline Mutations on Multigene Panel Testing.
    Int J Radiat Oncol Biol Phys. 2022;112:437-444.
    PubMed     Abstract available


    January 2022
  112. ABRAHAM A, Sanghera KP, Gheisari F, Koumna S, et al
    Is radiation-induced cardiac toxicity reversible? Prospective evaluation of breast cancer patients enrolled in a phase-III randomized controlled trial.
    Int J Radiat Oncol Biol Phys. 2022 Jan 24. pii: S0360-3016(22)00065.
    PubMed     Abstract available


  113. WARD MC, Bentzen SM, Fasola CE, Khan AJ, et al
    An Estimate of Local Failure in the TARGIT-A Trial of Pre-pathology Intraoperative Radiation Therapy for Early Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2022 Jan 19. pii: S0360-3016(21)03434.
    PubMed     Abstract available


  114. BELLON JR, Tayob N, Yang DD, Tralins J, et al
    Local therapy outcomes and toxicity from the (anonymized for review) trial: A phase II randomized trial of adjuvant trastuzumab emtansine vs. paclitaxel in combination with trastuzumab in women with stage I HER2-positive breast cancer.
    Int J Radiat Oncol Biol Phys. 2022 Jan 3. pii: S0360-3016(21)03446.
    PubMed     Abstract available


  115. BACHIR B, Anouti S, Jaoude JA, Kayali M, et al
    Evaluation of Cardiotoxicity in HER-2 Positive Breast Cancer Patients Treated with Radiation Therapy and Trastuzumab.
    Int J Radiat Oncol Biol Phys. 2022 Jan 2. pii: S0360-3016(21)03432.
    PubMed     Abstract available


  116. SHUMWAY DA, Corbin KS, Mutter RW
    Improving the Therapeutic Ratio Among Older Women With Early Stage Breast Cancer by Reevaluating Adjuvant Radiation Therapy and Hormone Therapy.
    Int J Radiat Oncol Biol Phys. 2022;112:52-55.
    PubMed    


    December 2021
  117. VICINI F, Broughman J, Halima A, Mayo Z, et al
    Delivery of Adjuvant Radiation in 5 Days or Less After Lumpectomy for Breast Cancer: A Systematic Review.
    Int J Radiat Oncol Biol Phys. 2021 Dec 15. pii: S0360-3016(21)03233.
    PubMed     Abstract available


    November 2021
  118. SIT D, Lalani N, Chan E, Tran E, et al
    Association between regional nodal irradiation and breast cancer recurrence-free interval for patients with low-risk, node-positive breast cancer.
    Int J Radiat Oncol Biol Phys. 2021 Nov 8. pii: S0360-3016(21)03072.
    PubMed     Abstract available


  119. MA DC, Potters L, Lee L, Bloom BF, et al
    Patient-Reported Outcomes Using Automated Chatbot for Breast Cancer Patients Receiving Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  120. LIANG X, Li N, Zhou X, Jin H, et al
    Evaluation of Automated Breast Cancer Contour Propagation From Planning CT to Cone Beam CT Based on Deep Learning.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  121. TAKAYESU J, Sapir E, Xie J, Sun Y, et al
    Survival Outcomes and Symptom Benefit From Palliative Radiotherapy in Breast Cancer Patients With Leptomeningeal Disease.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  122. SHUMWAY JW, Torras M, Hayes KR, Jolly T, et al
    Outcomes of Patients With HER2-Positive Breast Cancer Metastatic to Brain Treated With HER2-Targeted Systemic Therapy and Stereotactic Radiosurgery.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  123. MILLIGAN MG, Aitelli A, Mehan WA, Shi DD, et al
    Leptomeningeal Disease in Breast Cancer: Pre-Treatment Prognostic Factors and Outcomes.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  124. SAID BI, Chen H, Jerzak K, Myrehaug SD, et al
    T-DM1 Increases the Risk of SRS-Induced Radiation Necrosis in Her2+ Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  125. PERRON-GAGNON L, Archambault L, Varfalvy N, Piron O, et al
    Breast Deformations Measured With Cone Beam Computed Tomography During Adjuvant Radiotherapy for Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  126. LEE JJB, Lee IJ, Choi Y, Jeon MJ, et al
    Clinical Implications of Geometric and Dosimetric Uncertainties Due to Inter- and Intra-Fractional Movement During Volumetric Modulated Arc Therapy for Breast Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  127. GIANTSOUDI D, Lalonde A, Colleen B, Vanbenthuysen L, et al
    Tattoo-Free Set-ups for Breast Cancer Patients Receiving Regional Nodal Irradiation: Evaluation of Accuracy and Time Efficiency.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  128. XIN X, Zhang D, Zhao Y, Wang P, et al
    Overview of the Dosimetry of Free Breathing and Breath Hold Forward Intensity Modulated Treatments in a Large Clinical Series of Left-Sided Breast Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  129. MURAKAMI Y, Murakami Y, Kamima T, Abo N, et al
    Dosimetric Comparison Between 3D Conformal Radiation Therapy Plus Electron Boost and Simultaneous Integrated Boost Volumetric Modulated Arc Therapy for Left-Sided Breast Cancer Patients With a Potential Risk of Radiation-Induced Cardiac Toxicity.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  130. MLADKOVA N, Smith TL, Yildiz V, Healy E, et al
    The Impact of Bioabsorbable 3D Fiducial Marker on Radiation Dosimetry and Cosmesis in Early Stage Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  131. FAIRCHILD AM, Hill J, Alhumaid M, Ghosh S, et al
    Palliative Radiotherapy Delivery by a Dedicated Multidisciplinary Supportive Care Team: Facilitating Early Integration of Palliative Care for Patients With Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  132. HILL J, Alhumaid M, Ghosh S, Le A, et al
    Efficiency of Radiotherapy Delivery for Patients With Breast Cancer in a Dedicated Multidisciplinary Palliation Radiation Oncology Clinic.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  133. ALHUMAID M, Hill J, Ghosh S, Watanabe SM, et al
    Comprehensive Assessment of Care Needs During Palliative Radiotherapy Consultation Optimizes Provision of Supportive Care for Patients With Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  134. NICHOLS EM, DeCesaris C, Paulosky K, McAvoy SA, et al
    Cardiac Risk Factors in Black Women With Breast Cancer Undergoing Proton Therapy (PBT): Potential for Increased Therapeutic Gain.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  135. MCGUNIGAL M, Bhatt R, Aghdam N
    Sociodemographic Predictors of Stage IV Breast Cancer Presentation in a Vulnerable Patient Population.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  136. BOYCE-FAPPIANO D, Bedrosian I, Shen Y, Lin HY, et al
    Evaluation of Overall Survival and Barriers to Surgery for Breast Cancer Patients Treated Without Surgery.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  137. GRIFFITH T, Parsons MW, Tward JD, Tao R, et al
    Risk of Secondary Breast Cancer in Female Non-Hodgkin Lymphoma Survivors: 40 Years of Follow-Up Assessed by Treatment Modality.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  138. KINSLOW CJ, Krishnamurthy PB, Sanchez GI, Wang TJC, et al
    Risk of Anaplastic Large Cell Lymphoma After Post-Mastectomy Implant-Reconstruction for Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  139. ZHANG Y, Chen F, Jing H, Xu LL, et al
    Radiotherapy Induced Dynamic Changes of Circulating Blood Immune Cell Subsets in Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  140. KANG BH, Jang BS, Kim IA
    Radiosensitivity and Immune Cell Infiltration Signature Predict Clinical Outcome of Patients in the Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) Study Cohort.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  141. CHEN F, Jin JY, Nong Y, Wang W, et al
    Radiation Induced Lymphopenia Can Be Predicted by the Effective Dose to the Circulating Immune Cells (EDIC) in Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  142. RAHIMI AS, Kim DN, Leitch M, Gu X, et al
    Early Follow-Up of Multi-Institutional Trial of Phase I Dose Escalation Using Single Fraction Stereotactic Partial Breast Irradiation (S-PBI) for Early-Stage Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  143. CHEN C, Zheng S, Cao L, Cai G, et al
    Comparison of Prognosis Between Breast Conserving Therapy and Mastectomy in Early Breast Cancer: A Propensity Score Matching Analysis.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  144. ZHAI YR, Wen G, Wang SL, Zhang Y, et al
    Systemic Inflammation-Immune Status Score Predicts the Incidence of Radiation Induced Pneumonitis in Patients With Breast Cancer After Whole Breast Irradiation: A Result From Two Medical Centers.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  145. PINNARO P, Takanen S, Landoni V, Vici P, et al
    Ten Fraction Adjuvant Hypofractionated Radiotherapy in Node Positive Breast Cancer: 3 Year-Follow-Up of a Phase II Toxicity Study.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  146. SMITH AW, Kerns SL, Rowley JP, Moshier E, et al
    Quantifying Risk of Ipsilateral Arm Lymphedema Causing Functional Impairment in Breast Cancer Patients: Results From a Prospective, Multi-Centre International Study of Treatment Toxicity.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  147. MOON JY, Chang JS, Chung SY, Park RH, et al
    Machine Learning Based Analysis of Heart and Cardiac Substructures for Radiation-Induced Cardiac Toxicity From Breast Cancer Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  148. JIANG Z, Diao P, Liang Y, Dai K, et al
    A Light Gradient Boosting Machine-Enabled Early Prediction of Cardiotoxicity for Breast Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  149. HALL J, Fried DV, Marks LB, Gupta GP, et al
    Dosimetric and Clinical Factors Associated With Increased Risk of Reconstruction Complications in Patients With Breast Cancer Receiving Post-Mastectomy Radiation.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  150. ALLALI S, Beddok A, Servois V, Fourquet A, et al
    Assessment of Side Effects of Radiation Therapy in Patients With COVID-19 Treated for Early-Stage Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  151. CHUN J, Chang JS, Park I, Kim JS, et al
    Cardiac Substructure Delineation Based on Synthetic Contrast-Enhanced CT Generation Using Deep Convolutional Neural Network in Breast Cancer Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  152. LOAP P, Laki F, Beuzeboc P, Fourquet A, et al
    Long-Term Survival and Toxicity in Patients Treated With Radiotherapy for Neuroendocrine Breast Cancer: A Single-Center Experience.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  153. LIAO D, Singh K, Helou J, Fyles A, et al
    Impact of the COVID-19 Pandemic on Radiotherapy Patterns of Practice for Curative Intent Breast Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  154. SUN G, Zhang J, Wang SL, Tang Y, et al
    Tumor-Infiltrating Lymphocytes and Prognosis in Stage I-III Triple-Negative Breast Cancer: A Retrospective Analysis of 258 Patients Treated Without Neoadjuvant Therapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  155. ZHAO X, Guo N, Ma C, Yan XN, et al
    Mapping of Level I Axillary Lymph Nodes in Patients With Newly Diagnosed Breast Cancer: Optimal Target Delineation and Treatment Techniques in Breast and Level I Axilla Irradiation.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  156. WARD KA, Muller DA, Dutta SW, Malhi J, et al
    Long-Term Adherence to Adjuvant Endocrine Therapy Following Various Radiotherapy Modalities in Hormone Receptor Positive Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  157. WALLACE AS, Culbert M, Rocque G, Keene KS, et al
    Satisfaction and Regret With Decision Making in Older Women With Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  158. SUN G, Wen G, Zhang YJ, Tang Y, et al
    Risk Factors to Identify the Indication for Regional Nodal Irradiation in T1-2N1M0 Breast Cancer: A Joint Analysis of 4243 Real-World Cases From Two Institutions.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  159. SONG Y, Sun G, Wang S, Zhang J, et al
    Quality of Life After Partial or Whole Breast Irradiation After Breast-Conserving Surgery for Low-Risk Breast Cancer: 1-Year Results of a Phase 2 Randomized Controlled Trial.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  160. SITTENFELD SMC, Zabor E, Hamilton SN, Kuerer HM, et al
    Impact of Post-Mastectomy Radiation Therapy in Women With T1-2N1M0 Breast Cancer With Sentinel Lymph Node Biopsy Alone.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  161. SIT D, Lalani N, Chan EK, Tran E, et al
    Regional Nodal Irradiation for Low-Risk, Node-Positive Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  162. SHUKLA U, Langner UW, Tan S, Linshaw D, et al
    Comparison of Tumor Bed Delineation Using a Novel Radiopaque Filament Marker vs. Surgical Clips for Targeting Breast Cancer Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  163. SEOL SW, Pflederer T, Weller L, Goodman CR, et al
    A Comparison of Outcomes in Early Breast Cancer After External Beam Radiotherapy, Intraoperative Radiotherapy, or Observation: A Retrospective Cohort Study Across a Large Health System.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  164. SEOL SW, Weller L, Pflederer T, Goodman CR, et al
    A Comparison of Outcomes in Early-Stage Breast Cancer After External Beam Radiotherapy, Endocrine Therapy, Both, or Neither: A Retrospective Cohort Study Across a Large Health System.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  165. SCHLAFSTEIN A, Torres M, Rupji M, Brown G, et al
    Radiotherapy for Breast Cancer, Systemic Inflammation, and Cancer Recurrence.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  166. RESHKO LB, Pan J, Rai SN, Ajkay N, et al
    Five-Year Report of the Institutional Phase II Trial of Once Weekly Hypofractionated Whole Breast Irradiation for Early-Stage Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  167. RAJ R, Jhawar SR, Stover D, Park KU, et al
    De-Escalation of Radiation Therapy in Patients with cT1-T2 (< 3 cm) N0 HER2+ Breast Cancer Treated With Neoadjuvant Systemic Therapy With Pathologic Complete Response at the Time of Breast Conserving Surgery.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  168. MARK RJ, Gorman V, Wolski M, McCullough S, et al
    Five Day Accelerated Partial Breast Irradiation (APBI) Using Stereotactic Body Radiation Therapy (SBRT) in Stage 0-II Breast Cancer: A Report of 218 Cases With Up to 39 Month Follow-Up.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  169. OOI KH, Koh WY, Ho F, Tseng MSF, et al
    Efficacy and Safety of Adjuvant Breast Radiation Therapy for Patients With Early-Stage Breast Cancer: A Systematic Review and Network Meta-Analysis.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  170. MA SJ, Yu B, Oladeru OT, Bartl A, et al
    Evaluation of Adjuvant Radiation and Endocrine Therapy in Elderly Patients with Early-Stage Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  171. LORENZ J, Rizzo M, Patel SA, Kahn ST, et al
    Five-Year Results from a Single Institution Utilizing IORT for Early-Stage Breast Cancer in a Population Comprised of a Majority of African American Women.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  172. GIAP F, Bradley JA, Vega RM, Bates JE, et al
    Treatment of PRIME II Eligible Women With Early-Stage Breast Cancer: A National Cancer Database Analysis.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  173. FAHEY M, Mills MN, Liveringhouse C, Ronica N, et al
    Adherence to Endocrine Therapy Predicts Short-Term Clinical Outcomes for Postmenopausal Women With Luminal B but Not Luminal A Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  174. CHOUDHURY LS, Moran A, Daly ME, Monjazeb AM, et al
    An Analysis of Daily Setup Variation in Prone Breast Radiation of Early-Stage Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  175. CHEVLI NC, Haque W, Tran KT, Farach AM, et al
    21-Gene Recurrence Score Predictive for Patients Most Likely to Benefit From Postoperative Radiation Following Breast Conserving Surgery for T1N0 Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  176. CHEN F, Yu H, Nong Y, Jing H, et al
    Risk Factors for Radiation Induced Lymphopenia in Patients With Breast Cancer: Does Radiotherapy Technique Matter?
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  177. SYED ANM, Chang H, Hodge W, Reiner SD, et al
    Ethnic and Racial (E/R) Differences in Early-Stage Breast Cancer Patients (Pts) Successfully Treated With Intra-Operative Radiation Therapy (IORT) Using Electronic Brachytherapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  178. MUSHONGA M
    Hypofractionated Radiotherapy for Breast Cancer: Findings From an International ESTRO-GIRO Survey.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  179. LIN JY, Yang X, Miller AH, Godette KD, et al
    A Pilot Study of Hypofractionated Simultaneous Integrated Boost Radiotherapy in Stage 0-IIIB Breast Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  180. KIM DY, Park E, Heo CY, Jin US, et al
    Hypofractionated vs. Conventional Radiotherapy in Breast Cancer Patients Who Underwent Breast Reconstruction: Toxicity Analysis.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  181. ROSTOM Y, Mahmoud N, Abdelmoneim SE, Shaker M, et al
    Outcomes of Adjuvant Hypofractionated Radiotherapy in the Treatment of Post-Mastectomy Breast Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  182. ZHAO X, Xuan L, Yin J, Tang Y, et al
    Radiotherapy in Breast Cancer Patients With Isolated Regional Recurrence After Mastectomy: A Joint Analysis of 144 Cases From Two Institutions.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  183. WANG M, Chen J, Qi WX, Cao L, et al
    Using Inflammatory Blood Markers as Useful Prognostic Factors in Patients Undergoing Neo-Adjuvant Therapy for Stage II-III Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  184. PURSWANI J, Oh C, Xiao J, Barbee D, et al
    Boost to Unresectable Nodal Disease in Locally Advanced Breast Cancer: Outcomes and Toxicity.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  185. NARAYAN P, Flynn J, Zhang Z, Gillespie EF, et al
    Perineural Invasion as a Risk Factor for Locoregional Recurrence of Invasive Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  186. KIM BH, Cho MJ, Kwon J
    Potential Intrinsic Subtype Dependence on the Association Between Metformin Use and Survival in Surgically Resected Breast Cancer: A Korean National Population-Based Study.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  187. KIM JK, Karp JM, Gerber NK
    Isolated Tumor Cells and Micrometastatic Nodal Disease in Breast Cancer Patients After Neoadjuvant Chemotherapy: Is Post Mastectomy Radiation Therapy Indicated?
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  188. ANDRING LM, Diao K, Sun SX, Patel MM, et al
    Prognostic Factors in Breast Cancer Patients With Clinical N3b (Ipsilateral Internal Mammary and Axillary) Disease.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  189. CHU CN, Chan KHC, Wu RSC
    FR-101 Dressing May Alleviate Radiation-Irritated Skin After Radiotherapy in Breast Cancer Patients - A Pilot Clinical Trial.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  190. MO A, Chung J, Eichler J, Yukelis S, et al
    Breast Cancer Survivorship Care During the COVID-19 Pandemic Within an Urban New York Hospital System.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  191. YUSUF MB, Pan J, Rai SN, Eldredge-Hindy HB, et al
    Financial Toxicity in Women with Breast Cancer Receiving Radiotherapy: Final Results of a Prospective Observational Study.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  192. WEISS M, Danese S, Ruiz KA, Kjelstrom S, et al
    A Survey of Breast Cancer Patients' Use of Cannabis During Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  193. YU J, Wroe A, Acosta M, Fagundes MA, et al
    Impact of Dose Calculation Algorithm on Skin Dose for Breast Cancer Treated With Intensity Modulated Proton Therapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  194. DAI Z, Liang X, Zhu L, Tan J, et al
    Deep Learning-Based Automatic Delineation of Target Volumes and Organs at Risk of Breast Cancer for On-Line Dosimetric Evaluation.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  195. BYUN HK, Chang JS, Choi MS, Chun J, et al
    Evaluation of Deep Learning-Based Auto-Segmentation of Organs-at-Risk for Breast Cancer Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  196. LOAP P, Loirat D, Berger F, Rodrigues M, et al
    One-Year Toxicity Report of the RADIOPARP Phase I Trial Evaluating Olaparib With Radiotherapy for Triple Negative Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  197. SERRA D, Fleishman S, White C, Welsh C, et al
    Effectiveness of Traditional Acupuncture in Reducing the Severity of Hot Flashes Reported by Breast Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  198. BACHIR B, Anouti S, Jaoude JA, Kayali M, et al
    Evaluation of Cardiotoxicity in HER-2 Positive Breast Cancer Patients Treated With Radiation Therapy and Trastuzumab.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  199. NELSON CJ, Ahern T, Brennan S, Kerrigan C, et al
    A Pilot Study to Quantify Breast Lymphedema for Patients Undergoing Breast Conserving Therapy (BCT) for Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  200. MANKUZHY N, Grzywacz VP 2nd, Quinn TJ, Jawad MS, et al
    Thirty-Year Single Institution Experience of Accelerated Partial Breast Irradiation for Early-Stage Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  201. CHEN S, Sun G, Wang S, Fang H, et al
    Delay in Initiating Postmastectomy Radiotherapy is Associated With Inferior Clinical Oncologic Outcomes for High-Risk Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  202. FORSTER T, Hommertgen A, Hafner MF, Arians N, et al
    Quality of Life After Simultaneously Integrated Boost With Intensity-Modulated vs. Conventional Radiotherapy Followed by Sequential Boost for Adjuvant Treatment of Breast Cancer: 2-Year Results of the Multicenter Randomized IMRT-MC2 Trial.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  203. BELLON JR, Tayob N, Burstein HJ, Partridge A, et al
    Local Therapy Outcomes and Toxicity From the ATEMPT Trial (TBCRC 033), a Phase II Randomized Trial of Adjuvant T-DM1 vs. TH in Women With Stage I HER2 Positive Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  204. CHOI IJ, Khan AJ, Mah D, McCormick B, et al
    Proton Reirradiation for Recurrent or New Primary Breast Cancer in the Setting of Prior Breast Irradiation.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  205. DIAA M, Mohammmed T, Abd Elshaheed WH, Bayomy M, et al
    The Impact of Regional Nodal Irradiation on the Outcomes After Neoadjuvant Chemotherapy in Node Positive Breast Cancer Patients With ypN0: Interim Analysis of a Prospective Randomized Trial.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  206. DIAO K, Andring LM, Barcenas CH, Singh P, et al
    Outcomes After Multimodality Therapy in Modern Breast Cancer Patients Presenting With Clinical N3c Supraclavicular Node Involvement.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  207. NAOUM GE, Ioakeim-Ioannidou M, Shui AM, Salama L, et al
    Analysis of Radiation Modality and Timing on Complication Rates in Breast Cancer Patients Receiving Two-Stage Expander/Implant Reconstruction.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  208. KIM YB, Byun HK, Kim DY, Ahn SJ, et al
    Elective Internal Mammary Node Irradiation in Women With Node-Positive Breast Cancer: Results of a Randomized, Phase 3 Trial.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


    October 2021
  209. JAGSI R, Griffith KA, Vicini FA, Abu-Isa E, et al
    Disease Control After Hypofractionation Versus Conventional Fractionation for Triple Negative Breast Cancer: Comparative Effectiveness in a Large Observational Cohort.
    Int J Radiat Oncol Biol Phys. 2021 Oct 27. pii: S0360-3016(21)02918.
    PubMed     Abstract available


  210. RAHIMI A, Simmons A, Kim DN, Leitch M, et al
    Preliminary Results of Multi-Institutional Phase I Dose Escalation Trial Using Single Fraction Stereotactic Partial Breast Irradiation for Early Stage Breast Cancer: Dose Escalated Single Fraction Stereotactic PBI.
    Int J Radiat Oncol Biol Phys. 2021 Oct 19. pii: S0360-3016(21)02916.
    PubMed     Abstract available


  211. SAULSBERRY L, Liao C, Huo D
    Hypofractionated Radiotherapy for Breast Cancer: Financial Risk and Expenditures in the U.S. 2008-2017: Expenditure of Hypofractionated Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2021 Oct 9. pii: S0360-3016(21)02901.
    PubMed     Abstract available


  212. CUTTINO LW, McCall L, Kubicky C, Ballman KV, et al
    The Feasibility of Radiotherapy after Breast-Conserving Surgery for Multiple Ipsilateral Breast Cancer: An Initial Report from ACOSOG Z11102 (Alliance) Trial.
    Int J Radiat Oncol Biol Phys. 2021 Oct 8. pii: S0360-3016(21)02872.
    PubMed    


  213. JAGSI R, Griffith KA, Moran JM, Matuszak MM, et al
    Comparative Effectiveness Analysis of 3D-Conformal Radiotherapy versus Intensity Modulated Radiotherapy (IMRT) in a Prospective Multicenter Cohort of Breast Cancer Patients.
    Int J Radiat Oncol Biol Phys. 2021 Oct 8. pii: S0360-3016(21)02871.
    PubMed     Abstract available


  214. VAN VELZEN SGM, Gal R, Teske AJ, van der Leij F, et al
    AI-based radiation dose quantification for estimation of heart disease risk in breast cancer survivors after radiotherapy.
    Int J Radiat Oncol Biol Phys. 2021 Oct 5. pii: S0360-3016(21)02791.
    PubMed     Abstract available


  215. KIM DY, Park E, Heo CY, Jin US, et al
    Influence of Hypofractionated versus Conventional Fractionated Postmastectomy Radiotherapy in Breast Cancer Patients with Reconstruction.
    Int J Radiat Oncol Biol Phys. 2021 Oct 2. pii: S0360-3016(21)02835.
    PubMed     Abstract available


  216. WENG JK, Lei X, Schlembach P, Bloom ES, et al
    Five-Year Longitudinal Analysis of Patient-Reported Outcomes and Cosmesis in a Randomized Trial of Conventionally Fractionated Versus Hypofractionated Whole-Breast Irradiation.
    Int J Radiat Oncol Biol Phys. 2021;111:360-370.
    PubMed     Abstract available


    August 2021
  217. DIAO K, Andring LM, Barcenas CH, Singh P, et al
    Contemporary Outcomes after Multimodality Therapy in Breast Cancer Patients Presenting with Ipsilateral Supraclavicular Node Involvement.
    Int J Radiat Oncol Biol Phys. 2021 Aug 20. pii: S0360-3016(21)02714.
    PubMed     Abstract available


    June 2021
  218. RESHKO LB, Pan J, Rai SN, Ajkay N, et al
    Final Analysis of a Phase II Trial of Once Weekly Hypofractionated Whole Breast Irradiation for Early Stage Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2021 Jun 25. pii: S0360-3016(21)00744.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.